The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

In recent months, bird flu has started raising red flags among scientists and public health officials. Apoorva Mandavilli, a New York Times reporter who covers infectious diseases, explains why we ...